Open AccessInsight into 144 patients with ocular vascular events during VEGF antagonist injections
Author(s) -
Ahmad M Mansour,
Maha Shahin,
Peter Kristian Kofoed,
Maurízio Battaglia Parodi,
Michel Shami,
Stephen G Schwartz
Publication year - 2012
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s29075
Subject(s) - medicine , ranibizumab , ophthalmology , bevacizumab , intraocular pressure , central retinal vein occlusion , population , visual acuity , central retinal vein , retinal , glaucoma , vascular endothelial growth factor , surgery , vegf receptors , chemotherapy , macular edema , environmental health
To record ocular vascular events following injections of vascular endothelium growth factor (VEGF) antagonists.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom